GlassScriptPhysician profile
Christopher L Oliver
NPI 1891956421
$2,647.79
in general payments reported to CMS, 2019-2025
11 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.88 · 2020: $70.61 · 2021: $70.06 · 2022: $231 · 2024: $1,253 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,369 · Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,368.90 |
| Food and Beverage | $893.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,133.56 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Intuitive Surgical, INC. | $716.54 | 2025 | |
| Depuy Synthes Sales INC. | $234.43 | 2022-2025 | Trumatch |
| Stryker Corporation | $168.31 | 2025 | Na, Core, Sonopet Iq |
| Genzyme Corporation | $121.20 | 2022 | |
| Atos Medical INC | $70.61 | 2020 | |
| Lumenis, INC | $70.06 | 2021 | |
| Celgene Corporation | $66.44 | 2024 | Reblozyl |
| Kls-Martin L.P. | $34.42 | 2024 | |
| Olympus America INC. | $18.34 | 2024 | Olympus |
| Ethicon US, LLC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.